Annual Secretarial Compliance Report for the year ended on 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eiko Lifesciences Limited has filed its Annual Secretarial Compliance Report for FY 2025-26, certified by Practicing Company Secretary Shravan A. Gupta. The report states that the company has complied with all applicable SEBI regulations including LODR, ICDR, SAST, and PIT Regulations. All 13 compliance parameters examined show 'Yes' or 'Not Applicable' status with no adverse observations. One notable finding is that SEBI imposed a penalty of Rs 1 lakh on the company's Promoter Group Entity (Lenus Finvest Private Limited) in January 2026 for non-disclosure of margin pledge transactions between November 2019 to June 2021 under SAST Regulations. The company also certified compliance with Structured Digital Database requirements for insider trading, having captured 10 events during the year.
Overall positive compliance status with the minor regulatory penalty being on a promoter group entity rather than the listed company itself. This is unlikely to have significant impact on the stock but reflects ongoing regulatory scrutiny on promoter disclosures.